Advertisement
UK markets closed
  • FTSE 100

    8,384.71
    +30.66 (+0.37%)
     
  • FTSE 250

    20,539.83
    +47.84 (+0.23%)
     
  • AIM

    782.85
    +3.02 (+0.39%)
     
  • GBP/EUR

    1.1612
    -0.0011 (-0.09%)
     
  • GBP/USD

    1.2516
    +0.0019 (+0.15%)
     
  • Bitcoin GBP

    49,565.22
    -125.49 (-0.25%)
     
  • CMC Crypto 200

    1,330.24
    +30.15 (+2.32%)
     
  • S&P 500

    5,206.34
    +18.67 (+0.36%)
     
  • DOW

    39,242.32
    +185.93 (+0.48%)
     
  • CRUDE OIL

    79.22
    +0.23 (+0.29%)
     
  • GOLD FUTURES

    2,340.30
    +18.00 (+0.78%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,686.32
    +187.94 (+1.02%)
     
  • CAC 40

    8,185.27
    +53.86 (+0.66%)
     

AIG and SolarEdge rise while Mylan and Phibro fall

AIG and SolarEdge Technologies rise while Mylan and Phibro fall

NEW YORK (AP) -- Stocks that moved substantially or traded heavily on Tuesday:

American International Group Inc., up $3.19 to $50.30

The insurer reported solid underwriting gains in the first quarter and profit beat Wall Street forecasts.

Mylan NV, down $6.73 to $21.53

The generic drugmaker's first quarter revenue fell short of Wall Street forecasts.

Apple Inc., down $5.62 to 202.86

Technology stocks sold off amid an escalating trade fight between the U.S. and China.

The Mosaic Co., down $2.02 to $23.25

The fertilizer maker cut its full-year profit forecast because of higher costs for regulations and taxes.

ADVERTISEMENT

Regeneron Pharmaceuticals Inc., down $21.83 to $322.40

The drugmaker's first quarter profit and revenue missed analysts' forecasts.

Phibro Animal Health Corp., down $7.86 to $28.99

The maker of animal health products and supplements fell short of Wall Street's profit and revenue forecasts.

SolarEdge Technologies Inc., up $9.96 to $53.84

The photovoltaic products maker gave investors a better-than-anticipated revenue forecast for the second quarter.

Henry Schein Inc., up $3.43 to $66.71

The health care products company beat Wall Street's first quarter profit and revenue forecasts.